Yahoo
NasdaqGM - Nasdaq Real Time Price USD

Entrada Therapeutics, Inc. (TRDA)

6.90 +0.40 (+6.15%)
As of 2:31:31 PM EDT. Market Open.
Trade TRDA on Coinbase
Chart Range Bar
Loading chart for TRDA
  • Previous Close 6.50
  • Open 6.54
  • Bid 5.02 x 200
  • Ask 8.56 x 200
  • Day's Range 6.54 - 7.06
  • 52 Week Range 4.93 - 16.45
  • Volume 119,171
  • Avg. Volume 362,879
  • Market Cap (intraday) 267.862M
  • Beta (5Y Monthly) -0.26
  • PE Ratio (TTM) --
  • EPS (TTM) -4.00
  • Earnings Date (est.) Aug 5, 2026
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est 18.75

Entrada Therapeutics, Inc., is a clinical-stage biopharmaceutical company aiming to transform the lives of patients by establishing a new class of medicines that engage intracellular targets that have long been considered inaccessible. The Company's Endosomal Escape Vehicle, therapeutic candidates are based on a novel therapeutic; a robust development portfolio of genetic medicines for the potential treatment of neuromuscular and inherited retinal diseases. Its preclinical product includes ENTR-601-44; ENTR-601-45; and VX-670. The company was formerly known as CycloPorters, Inc., and changed its name to Entrada Therapeutics, Inc., in October 2017. Entrada Therapeutics, Inc. was incorporated in 2016 and is headquartered in Boston, Massachusetts.

www.entradatx.com

152

Full Time Employees

December 31

Fiscal Year Ends

Healthcare

Sector

Biotechnology

Industry

Performance Overview

Trailing total returns as of 6/17/2026, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .

YTD Return

TRDA
32.88%
S&P 500 (^GSPC)
9.15%

1-Year Return

TRDA
4.30%
S&P 500 (^GSPC)
24.89%

3-Year Return

TRDA
53.54%
S&P 500 (^GSPC)
69.45%

5-Year Return

TRDA
73.96%
S&P 500 (^GSPC)
76.98%

Earnings Trends

View More

Earnings Per Share

GAAP
Normalized
GAAP
Normalized

Revenue vs. Earnings

Annual
Quarterly
Annual
Quarterly
Q1 FY26
Revenue 875k
Earnings -39.72M

Q2

FY25

Q3

FY25

Q4

FY25

Q1

FY26

-40M
-30M
-20M
-10M
0

Analyst Insights

View More

Analyst Price Targets

10.00
18.75 Average
6.90 Current
25.00 High

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell

Latest Rating

Date 6/8/2026
Analyst Guggenheim
Rating Action Maintains
Rating Buy
Price Action Lowers
Price Target 20 -> 17

Statistics

View More

Valuation Measures

Annual
As of 6/16/2026
  • Market Cap

    252.92M

  • Enterprise Value

    221.94M

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    47.19

  • Price/Book (mrq)

    0.93

  • Enterprise Value/Revenue

    38.68

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    0.00%

  • Return on Assets (ttm)

    -26.84%

  • Return on Equity (ttm)

    -48.28%

  • Revenue (ttm)

    5.74M

  • Net Income Avi to Common (ttm)

    -166.12M

  • Diluted EPS (ttm)

    -4.00

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    254.86M

  • Total Debt/Equity (mrq)

    18.37%

  • Levered Free Cash Flow (ttm)

    -75.38M

Compare

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Company Insights

Fair Value

6.90 Current

Dividend Score

0 Low
Sector Avg.
100 High

Hiring Score

0 Low
Sector Avg.
100 High

Insider Sentiment Score

0 Low
Sector Avg.
100 High

Research Reports

View More
  • Daily – Vickers Top Buyers & Sellers for 07/14/2025

    The Vickers Top Buyers & Sellers is a daily report that identifies the five companies the largest insider purchase transactions based on the dollar value of the transactions as well as the five companies the largest insider sales transactions based on the dollar value of the transactions.

  • Daily – Vickers Top Buyers & Sellers for 05/17/2024

    The Vickers Top Buyers & Sellers is a daily report that identifies the five companies the largest insider purchase transactions based on the dollar value of the transactions as well as the five companies the largest insider sales transactions based on the dollar value of the transactions.

  • Daily – Vickers Top Buyers & Sellers for 03/27/2024

    The Vickers Top Buyers & Sellers is a daily report that identifies the five companies the largest insider purchase transactions based on the dollar value of the transactions as well as the five companies the largest insider sales transactions based on the dollar value of the transactions.

  • Daily – Vickers Top Buyers & Sellers for 03/22/2024

    The Vickers Top Buyers & Sellers is a daily report that identifies the five companies the largest insider purchase transactions based on the dollar value of the transactions as well as the five companies the largest insider sales transactions based on the dollar value of the transactions.

People Also Watch

Mobilize your Website
View Site in Mobile | Classic
Share by: